This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Gestational diabetes and driving

Authoring team

With respect to Group 1 entitlement to drive:

If temporary insulin treatment e.g. gestational diabetes, post-myocardial infarction, participants in oral/inhaled insulin trials.

  • provided they are under medical supervision and have not been advised by their doctor that they are at risk of disabling hypoglycaemia, need not notify DVLA. If experiencing disabling hypoglycaemia, DVLA should be notified
  • notify DVLA if treatment continues for more than 3 months or for more than 3 months after delivery for gestational diabetes

Otherwise guidance is as for diabetes and driving (linked item).

For up to date guidance then consult the DVLA website.

Reference

  1. DVLA. Assessing fitness to drive: a guide for medical professionals. Published March 2016, last updated August 2024

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.